Correlation Between Webus International and Spyre Therapeutics

Can any of the company-specific risk be diversified away by investing in both Webus International and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Webus International and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Webus International Limited and Spyre Therapeutics, you can compare the effects of market volatilities on Webus International and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Webus International with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Webus International and Spyre Therapeutics.

Diversification Opportunities for Webus International and Spyre Therapeutics

-0.52

Correlation Coefficient

Webus International  Spyre Therapeutics

Excellent diversification

The 3 months correlation between Webus and Spyre is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Webus International Limited and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Webus International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Webus International Limited are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Webus International i.e., Webus International and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Webus International and Spyre Therapeutics

Given the investment horizon of 90 days Webus International Limited is expected to under-perform the Spyre Therapeutics. In addition to that, Webus International is 3.04 times more volatile than Spyre Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.13 per unit of volatility. If you would invest  1,251  in Spyre Therapeutics on May 6, 2025 and sell it today you would earn a total of  365.00  from holding Spyre Therapeutics or generate 29.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Webus International Limited  vs.  Spyre Therapeutics

Webus International

Risk-Adjusted Performance

Very Weak

Over the last 90 days Webus International Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in September 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Spyre Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Spyre Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Webus International and Spyre Therapeutics

The main advantage of trading using opposite Webus International and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Webus International position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.

The idea behind Webus International Limited and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.